Axium QC-6-20-3DRecalls & reported problems
Micro Therapeutics, Inc. · QC-6-20-3D BARE AXIUM 3D COIL · Class 2 · Implant
All models of Axium (28)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00836462010390), received between Nov 20, 2019 and Apr 3, 2024 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Separation Failure” (2 reports).
2 other recalls cover devices cleared under the same FDA submission (K081465); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Separation Failure2
Patient problems
- No Clinical Signs, Symptoms or Conditions1
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionApr 3, 2024Separation Failure; Separation Failure
MEDTRONIC RECEIVED A REPORT THAT THE SPRING COILS (LOT 225631674 AND LOT 226051945) WERE STRETCHED AND SUCCESSFULLY IMPLANTED AFTER REPLACEMENT. THE SPRING COIL (LOT 225062459) WAS NOT DETACHED SMOOTHLY, BUT IT WAS SUCCESSFULLY DETACHED AND IMPLANTED AFTER REPLACEMENT. NO PATIENT SYMPTOMS OR FURTHER COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT. THE DEVICE AND ANY ACCESSORIES WERE PREPARED AS INDICATED IN THE IFU. THE PATIENT WAS UNDERGOING SURGERY FOR TREATMENT OF A CORONARY FISTULA. IT WAS NOTED THE PATIENT'S BLOOD FLOW WAS NORMAL AND VESSEL TORTUOSITY WAS NORMAL.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19032986 ↗MalfunctionNov 20, 2019Separation Failure; Separation Failure
MEDTRONIC RECEIVED INFORMATION THAT THERE WAS A NON-DETACHMENT ISSUE WITH THE AXIUM IMPLANT COIL. THE PHYSICIAN DID NOT ATTEMPT TO DETACH THE COIL WITH THE INSTANT DETACHER (ID). THEY ATTEMPTED TO DETACH THE COIL WITH THE MANUAL METHOD (BREAKING OF THE HYPO-TUBE, AN ALTERNATIVE DETACHMENT METHOD PRESENTED IN THE INSTRUCTIONS FOR USE) 3 (THREE) TIMES BUT WITHOUT SUCCESS. NO PATIENT INJURY WAS REPORTED AS A RESULT OF THE EVENT. THE PATIENT WAS UNDERGOING EMBOLIZATION TREATMENT OF AN UNRUPTURED FUSIFORM ANEURYSM WITH A 6.5MM DIAMETER. THE PATIENT'S BLOOD FLOW WAS NORMAL AND THE VASCULATURE WAS NORMAL IN TORTUOSITY. THE DOCTOR DIDN'T PREPARE THE INSTANT DETACHER (ID) BEFORE THE SURGERY. USED MICROCATHETER TO DELIVER THE SPRING COIL. A HEADWAY17 ( MICROVENTION) WAS USED. NO DAMAGE WAS NOTED TO THE PUSHWIRE. THE PATIENT WAS BEING TREATED FOR AN UNRUPTURED, FUSIFORM, BASILAR ARTERY, DISSECTING ANEURYSM. THE MAX DIAMETER WAS 6.5MM. THE BLOOD FLOW AND THE VESSEL ANATOMY WERE BOTH NORMAL. NO PATIENT INJURY OCCURRED.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9348411 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K081465. One submission often covers many models, so check the product and lot details in each record.
- Z-0873-2012 · Mar 1, 2010 · TerminatedAxium Detachable Coil System QC-2-1-Helix The ev3 Axium Detachable Coil System is indicated for the endovascular embolization of intracranial aneurysms and other neurovascular ab
- Z-0874-2012 · Mar 1, 2010 · TerminatedAxium Detachable Coil System QC-7-30-Helix The ev3 Axium Detachable Coil System is indicated for the endovascular embolization of intracranial aneurysms and other neurovascular a
Other Device, Vascular, for Promoting Embolization devices
- POD RBYPOD8-APenumbra, Inc. · Device, Vascular, For Promoting Embolization195 reports
- CEREPAKTM MDH1Cerenovus, Inc. · Device, Vascular, for Promoting Embolization1 recall72 reports
- Azur CX Detachable 45-750824Microvention, Inc. · Device, Vascular, for Promoting Embolization115 reports
- Tornado G08261Cook Incorporated · Device, Vascular, for Promoting Embolization2 recalls7 reports
- Optima Coil System OPTI0930CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls4 reports
- Optima Coil System OPTI0720CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls4 reports
- Optima Coil System OPTI0413CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls3 reports
- Prestige Coil System PRES0520HPKPLBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls3 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page